<DOC>
	<DOCNO>NCT02486939</DOCNO>
	<brief_summary>An Open-label , Safety Extension Study ( OLSES ) evaluate longer-term safety durability response subject complete 48 week evaluation confirmatory safety efficacy study , CHS 0214-02 CHS-0214-04 , evaluate CHS-0214 patient rheumatoid arthritis ( RA ) plaque psoriasis ( PsO ) , respectively .</brief_summary>
	<brief_title>A Long Term Safety Extension Study ( CHS-0214-05 )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Have complete 48 week evaluation CHS021402 , Week 48 , least ACR20 , complete 48 week evaluation CHS021404 , Week 48 , least PASI50</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>